Vincristine Sulphate Injection – Onvinc is a cytotoxic anticancer medicine containing Vincristine Sulphate, a vinca alkaloid used as part of combination chemotherapy for various hematological malignancies and selected solid tumors.

Vincristine works by binding to tubulin and interfering with the formation of microtubules required for cell division. This disrupts mitosis and inhibits the proliferation of rapidly dividing cancer cells.

Onvinc is administered intravenously by qualified healthcare professionals under the supervision of an oncologist. The dosage and treatment schedule depend on the patient’s diagnosis, chemotherapy protocol, body surface area, organ function, and treatment response.

What is Vincristine Sulphate?

Vincristine Sulphate is a vinca alkaloid antineoplastic agent that interferes with microtubule formation during mitosis. By preventing normal cell division, it contributes to the destruction or growth inhibition of susceptible cancer cells.

It is generally used as one component of a combination chemotherapy regimen rather than as a standalone treatment.

Benefits / Uses

Vincristine Sulphate Injection may be used as part of combination chemotherapy for:

• Acute lymphoblastic leukemia (ALL)
• Hodgkin lymphoma
• Non-Hodgkin lymphoma
• Neuroblastoma
• Wilms tumor
• Rhabdomyosarcoma
• Selected hematological malignancies
• Other malignancies according to established oncology protocols

The specific indication and combination of medicines should be determined by the treating oncologist.

Dosage Guidelines

Vincristine is administered intravenously only by appropriately trained healthcare professionals.

• The dose is generally calculated according to body-surface area and the applicable chemotherapy protocol.
• It is administered at specific intervals according to the prescribed treatment regimen.
• Dose adjustments may be required based on toxicity, liver function, age, and other clinical factors.
• Vincristine must never be administered intrathecally, as accidental intrathecal administration can be fatal.

The exact dose and administration schedule should always follow the prescribing information and oncologist’s instructions.

Wholesale & Supply

Onvinc – Vincristine Sulphate Injection can be supplied for hospitals, oncology centers, pharmaceutical distributors, wholesalers, and international healthcare markets, subject to applicable regulatory requirements.

Bulk pharmaceutical buyers can request:

• Available strengths and presentations
• Packaging configuration
• Minimum order quantity
• Production and supply capacity
• Certificate of Analysis (CoA)
• Product documentation
• Regulatory and export documents

Buying Online

Vincristine Sulphate is a prescription cytotoxic chemotherapy medicine and should only be procured through authorized pharmaceutical suppliers and used under qualified medical supervision.

Hospitals, licensed distributors, and healthcare procurement organizations can contact the supplier for product availability, commercial quotations, and applicable documentation.

Reviews

Individual responses to Vincristine-based chemotherapy vary depending on the cancer type, disease stage, treatment combination, and patient characteristics. Clinical treatment decisions should be based on professional medical assessment and established oncology protocols.

Quality Assurance

Onvinc should be manufactured and handled according to applicable pharmaceutical quality requirements. Quality-control testing for injectable products may include:

• Identity and assay
• Sterility
• Purity and related substances
• Appearance
• Particulate matter
• Container-closure integrity
• Stability testing
• Appropriate storage conditions

Product-specific quality and regulatory documentation can be provided upon request, where applicable.

Frequently Asked Questions

What is Onvinc used for?

Onvinc contains Vincristine Sulphate and is used as part of combination chemotherapy for several hematological malignancies and selected solid tumors.

What type of medicine is Vincristine Sulphate?

Vincristine Sulphate is a vinca alkaloid and cytotoxic antineoplastic medicine that interferes with microtubule formation and cell division.

How is Onvinc Injection administered?

Onvinc is administered intravenously by qualified healthcare professionals. It must not be administered intrathecally.

Is Vincristine used alone?

Vincristine is generally used as part of combination chemotherapy regimens with other anticancer medicines selected according to the specific cancer and treatment protocol.

What are the important side effects of Vincristine?

Potential adverse effects include peripheral neuropathy, constipation, abdominal discomfort, hair loss, and other chemotherapy-related toxicities. Neurological toxicity can be clinically significant and requires appropriate monitoring.

Does Onvinc require specialist supervision?

Yes. Vincristine is a potent cytotoxic chemotherapy medicine and should be prepared, administered, and monitored by appropriately trained healthcare professionals.

Conclusion

Onvinc – Vincristine Sulphate Injection is a vinca alkaloid chemotherapy medicine used in established combination treatment protocols for various hematological malignancies and selected cancers. Due to its cytotoxic activity and risk of serious neurological toxicity, it requires strict adherence to oncology protocols and professional intravenous administration.